LGALS1 and cancer: The potential effects of OTX008 on thrombosis and hemostasis have not been investigated; therefore, we only speculate that OTX008 may represent a potential therapeutic approach to target galectin-1-mediated platelet adhesion and platelet–neutrophil interactions in cancer.